Novavax gets $1.6B contract for COVID-19 vaccine work
A Gaithersburg-based biotechnology company has been awarded a $1.6 billion contract to continue working on a COVID-19 vaccine. The contract with Novavax - part of a government prog…
A Gaithersburg-based biotechnology company has been awarded a $1.6 billion contract to continue working on a COVID-19 vaccine. The contract with Novavax - part of a government prog…